amiodarone has been researched along with propafenone in 191 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (14.66) | 18.7374 |
| 1990's | 47 (24.61) | 18.2507 |
| 2000's | 73 (38.22) | 29.6817 |
| 2010's | 32 (16.75) | 24.3611 |
| 2020's | 11 (5.76) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Pajeva, IK; Wiese, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Evans, CA; Jolivette, LJ; Nagilla, R; Ward, KW | 1 |
| Bradley, KA; Damoiseaux, R; Gillespie, EJ; Huang, J; Manchester, M; Rogers, J; Sanchez, AM; Saxe, JP; Thomas, D | 1 |
| Cai, W; Hao, Y; Hu, P; Ma, D; Pan, H; Xie, X; Yu, AD; Yu, J; Yuan, J; Zhang, L; Zhu, H | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Cooper, J; Cui, Y; Fink, M; Gavaghan, DJ; Heath, BM; McMahon, NC; Mirams, GR; Noble, D; Sher, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Dalvie, D; Loi, CM; Smith, DA | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodherr-Heberlein, S; Engelhardt, W; Kienast, W; Kramer, HH; Lang, D; Lindinger, A; Schneider, P; Singer, H; Ulmer, H; von Bernuth, G | 1 |
| Baĭer, T; Brakhmann, I; Khilbel, T; Kiubler, V; Shmitt, K; Valdeker, B | 1 |
| Deiwick, M; Konertz, W; Scheld, HH; Weyand, M | 1 |
| Herms, J; Kuck, KH; Schneider, M; Siebels, J | 1 |
| Kokkas, B; Kotoula, M; Morali, A; Papadopoulos, K; Paradelis, A; Sphakianaki, E; Tsouderos, I | 1 |
| Rabkin, SW | 1 |
| Adragão, P; Bonhorst, D; Seabra-Gomes, R; Ventosa, A | 1 |
| Camerini, F; Chersevani, D; Dreas, L; Humar, F; Maras, P; Morgera, T | 1 |
| Ewing, DJ; Latini, R; Neilson, JM; Schwartz, PJ; Zuanetti, G | 1 |
| Bonnet, D; Cohen, L; Kachaner, J; Le Bidois, J; Piéchaud, JF; Sidi, D; Villain, E | 1 |
| Campbell, RW | 1 |
| Bettini, R; Cozzi, F; Dal Forno, P; Furlanello, F | 1 |
| Bauernfeind, RA; Welch, WJ | 1 |
| Brignole, M; Lolli, G; Menozzi, C; Monducci, I | 1 |
| Cosnay, P; Fauchier, JP; Huguet, R; Moquet, B; Rouesnel, P; Wajman, A | 1 |
| Fichtner, H; Kohlhardt, M | 1 |
| Kates, RE; Liem, LB | 1 |
| Somberg, J | 1 |
| Roden, DM; Siddoway, LA; Woosley, RL | 1 |
| Huang, SK; Marcus, FI | 1 |
| Garson, A; Moak, JP; Smith, RT | 1 |
| Lanza, GA; Lucente, M; Mondello Malvestiti, FM; Rebuzzi, AG; Tamburi, S | 1 |
| Bell, R; Eudy, S; Fan, K; Fullenwider, J | 1 |
| Capucci, A; Carini, G; Frabetti, L; Gubelli, S; Magnani, B | 1 |
| Schwartz, PJ; Vanoli, E | 1 |
| Podrid, PJ | 1 |
| Gang, ES; Hamer, A; Mandel, WJ; Oseran, DS; Peter, T; Rosenthal, ME | 1 |
| Sanna, GP | 1 |
| Camin, G; Disertori, M; Fiorentini, F; Furlanello, F; Guareneiro, M; Inama, G; Nicasi, L | 1 |
| Attuel, P; Coumel, P; Georgiopoulos, G; Halkidis, H; Leclercq, JF; Maisonblanche, P | 1 |
| Somberg, JC | 1 |
| Ceci, V; Di Marcotullio, G; Dini, P; Milazzotto, F; Polizzi, C; Santini, M | 1 |
| Lüderitz, B | 1 |
| Assayag, P; Coumel, P; Leclercq, JF | 1 |
| Bettini, R; Dal Forno, P; Disertori, M; Furlanello, F; Gramegna, L; Inama, G; Vergara, G | 1 |
| Heger, JJ; Prystowsky, EN; Zipes, DP | 1 |
| Delise, P; Di Pede, F; Piccolo, E; Raviele, A | 1 |
| Ambrosini, F; Finzi, A; Lo Masto, M; Lotto, A; Massari, FM; Pagnoni, F; Valentini, R | 1 |
| Bettini, R; Disertori, M; Durante, G; Furlanello, F; Guarnerio, M; Inama, G; Stirpe, E; Vergara, G | 1 |
| Coumel, P; Fidelle, J | 1 |
| Bonatti, V; Botti, G; Disertori, M; Furlanello, F; Guarnerio, M; Inama, G; Rolli, A; Vergara, G | 1 |
| Carlsson, B; Drvota, V; Häggblad, J; Sylvén, C | 1 |
| Parízek, P; Pidrman, V; Pleskot, M; Tilser, P | 1 |
| Beleslin, BB; Dekleva, MN | 1 |
| Cappato, R; Kuck, KH; Rüppel, R; Schneider, MA; Siebels, J | 2 |
| Dodo, H; Freedom, RM; Gow, RM; Hamilton, RM | 1 |
| Bauersfeld, U; Gow, RM; Hamilton, RM; Izukawa, T | 1 |
| Alfano, C; Rossini, E; Treglia, A | 1 |
| Kuck, KH; Siebels, J | 1 |
| Gutiérrez-Larraya, F; Jabón, A | 1 |
| Bellone, P; Spirito, P; Vecchio, C | 1 |
| Cowan, JC | 1 |
| Lüderitz, B; Manz, M | 1 |
| Brechenmacher, C; Chauvin, M; Koenig, A; Theolade, R | 1 |
| Bellandi, F; Cantini, F; Dabizzi, RP; Palchetti, R; Pedone, T | 1 |
| Foscoli, M; Giofrè, R; Labriola, E; Lolli, C; Tarquinii, M; Toschi, GP | 1 |
| Kosmala, W | 1 |
| Cappiello, E; Di Biasi, P; Mangini, A; Paje, A; Santoli, C; Scrofani, R | 1 |
| Roden, DM | 1 |
| Larbuisson, R; Stiels, B; Venneman, I | 1 |
| Broccolino, M; Mannucci, PM; Merlini, PA; Oltrona, L; Pezzano, A; Spinola, A | 1 |
| Kuhn, RJ; Luedtke, SA; McCaffrey, FM | 1 |
| Cruz Fernández, JM; García-Rubira, JC; Gómez-Barrado, JJ; Hidalgo Urbano, R; Montes Ramírez, JM; Pavón García, M; Turégano Albarrán, S | 1 |
| Epstein, LM; Huang, DT; Josephson, ME; Monahan, KM; Papageorgiou, P; Zimetbaum, P | 1 |
| Chang, MS; Chen, SA; Chen, YJ; Feng, AN; Tai, CT; Yu, WC | 1 |
| Chang, MS; Chen, SA; Ding, YA; Feng, AN; Kuo, BI; Lee, SH; Tai, CT; Yu, WC | 1 |
| Biffi, M; Boriani, G; Botto, G; Branzi, A; Broffoni, T; Capucci, A; Magnani, B; Ongari, M; Rubino, I; Sanguinetti, M; Trisolino, G | 1 |
| Igoumenidis, NE; Kochiadakis, GE; Marketou, ME; Mezilis, NE; Parthenakis, FI; Simantirakis, EN; Vardas, PE | 1 |
| Altamura, G; Castro, A; Gentilucci, G; Jesi, AP; Pandozi, C; Santini, M; Scianaro, MC; Toscano, S; Villani, M | 1 |
| Chlouverakis, GI; Igoumenidis, NE; Kochiadakis, GE; Parthenakis, FI; Vardas, PE | 1 |
| Candinas, R; Carrel, T; Meyer, B; Schmid, ER; Turina, M | 1 |
| Chang, MS; Chen, SA; Chen, YJ; Chiang, CE; Ding, YA; Feng, AN; Lee, SH; Tai, CT; Yu, WC | 1 |
| Blanc, JJ; Maarek, M; Voinov, C | 1 |
| Connolly, S; Dorian, P; Dubuc, M; Eisenberg, MJ; Gagné, P; Green, M; Kus, T; Lambert, J; Nattel, S; Roy, D; Talajic, M; Thibault, B | 1 |
| Dell'Orfano, JT; Luck, JC; Naccarelli, GV; Patel, HM; Wolbrette, DL | 1 |
| Aggarwal, A | 1 |
| Odeh, M; Oliven, A; Seligmann, H | 1 |
| Couturier, A; Dorian, P; Newman, D; Paquette, M; Roy, D; Talajic, M; Yang, C | 1 |
| Camacho, C; Fernández-Gómez, JM; García-Garmendia, JL; Martínez-Marcos, FJ; Ortega-Carpio, A; Santos, JM | 1 |
| Klein, GJ; Krahn, AD; Lee, JK; Simpson, C; Skanes, A; Spindler, B; Yee, R; Zarnke, K | 1 |
| Dorian, P; Pinter, A | 1 |
| Chrysostomakis, SI; Igoumenidis, NE; Kaleboubas, MD; Kochiadakis, GE; Marketou, ME; Mavrakis, HE; Vardas, PE | 1 |
| Bodor, E; Gellér, L; Matkó, I; Merkely, B; Moravcsik, E; Szabó, T; Szabolcs, Z; Turbók, E; Vágó, H | 1 |
| Knobloch, K; Wirth, KJ | 1 |
| Bagliani, G; Colella, A; Costoli, A; Franchi, F; Gensini, GF; Lazzeri, C; Michelucci, A; Padeletti, L; Pieragnoli, P; Sabini, A; Zipoli, R | 1 |
| Carfrae, L; Seto, W; Trope, A; Walker, S | 1 |
| Alboni, P; Bongiorni, MG; Botto, GL; Brignole, M; Bruna, C; Gasparini, M; Menozzi, C; Ometto, R; Verlato, R; Vincenti, A | 1 |
| Cabrera Duro, A; Galdeano Miranda, JM; Macua Biurrun, P; Martínez Corrales, P; Pastor Menchaca, E; Pilar Orive, J; Rodrigo Carbonero, D | 1 |
| Connolly, SJ; Dorian, P; Green, M; Newman, D; Paquette, M; Roy, D; Talajic, M | 1 |
| Klein, G; Krahn, A; Skanes, AC; Yee, R | 1 |
| Couturier, A; Dubuc, M; Frasure-Smith, N; Gagné, P; Lambert, J; Lumer, GB; Nattel, S; Roy, D; Talajic, M; Thibault, B | 1 |
| Calabrò, R; Cavallaro, C; D'Onofrio, A; Ducceschi, V; Musto, B; Musto, C; Sarubbi, B; Vecchione, F | 1 |
| Khairy, P; Nattel, S | 1 |
| Bhatta, L; Hynes, J; Khan, M; Luck, J; Naccarelli, GV; Samii, S; Wolbrette, DL | 1 |
| Kao, W; Kowey, PR; Winkel, E; Yan, GX | 1 |
| Jalil, E; Kus, T; Mensour, B; Vinet, A | 1 |
| Friberg, J; Gadsbøll, N | 1 |
| Hennersdorf, MG; Niebch, V; Perings, C; Strauer, BE; Vester, EG; Winter, J | 1 |
| Klein, GJ; Krahn, AD; Lee, JK; Simpson, C; Skanes, A; Yee, R; Zarnke, K | 1 |
| Lumer, G; Nattel, S; Roy, D; Talajic, M | 1 |
| Dorian, P; Mangat, I | 1 |
| Kohno, Y; Suzuki, A; Yamamoto, T | 1 |
| Hamilos, MI; Igoumenidis, NE; Klapsinos, NC; Kochiadakis, GE; Tzerakis, PG; Vardas, PE; Zacharis, EA | 1 |
| Borbély, M; Dani, G; Erdej, F; Hajdara, I; Katona, A; Márk, L; Nagy, E; Sziklai, G | 1 |
| Bleich, M; Brendel, J; Busch, AE; Knobloch, K; Rosenstein, B; Wirth, KJ | 1 |
| Dorian, P; Humphries, KH; Kerr, CR; Steinbuch, M | 1 |
| Bertaglia, E; Bonso, A; Corò, L; Mantovan, R; Pascotto, P; Proclemer, A; Raviele, A; Themistoclakis, S; Verlato, R; Zoppo, F | 1 |
| Freestone, B; Lip, GY | 2 |
| Block, JE; Calkins, H; Cher, D; Kocheril, AG; Sharma, AD; Stubbs, HA | 1 |
| Fragakis, N; Katsaris, G; Kozirakis, M; Maligkos, G; Papadopoulos, N; Papanastasiou, S; Tsaritsaniotis, E | 1 |
| Wysokiński, A; Zapolski, T | 1 |
| Scharf, C | 1 |
| Ata, N; Birdane, A; Cavusoglu, Y; Goktekin, O; Gorenek, B; Kudaiberdieva, G; Timuralp, B; Unalir, A | 1 |
| Chang, SL; Chen, SA; Lin, YJ; Tai, CT; Wongcharoen, W | 1 |
| Cao, J; Chen, DY; Zhu, BP | 1 |
| Lip, GY | 1 |
| Hoffmann, E; Janko, S | 1 |
| Dong, J; Fang, D; Hao, P; He, X; Hu, F; Liu, X; Long, D; Lu, C; Ma, C; Tang, R; Yu, R | 1 |
| Chen, CY; Chen, YY; Leung, KK | 1 |
| Fodstad, H; Kontula, K; Laitinen-Forsblom, P; Lehtonen, A; Swan, H; Toivonen, L | 1 |
| Bauman, JL; Kehoe, RF; Leal, S; Mykytsey, A; Razminia, M; Saleem, M; Wang, T; Zheutlin, T | 1 |
| Chlouverakis, GI; Hamilos, ME; Igoumenidis, NE; Kochiadakis, GE; Marketou, ME; Vardas, PE | 1 |
| Boriani, G; Chiarandà, G; Colletti, A; Di Giovanni, N; Grammatico, A; Gulizia, M; Lisi, F; Mangiameli, S; Orazi, S; Pensabene, O; Piccione, G; Vasquez, L | 1 |
| Antzelevitch, C; Belardinelli, L; Burashnikov, A; Di Diego, JM; Zygmunt, AC | 1 |
| Aytekin, S; Aytekin, V; Men, EE; Tuğcu, A; Yildirimtürk, O | 1 |
| Bett, GC; Chen, J; Huang, C; Jiang, X; Li, X; Rasmusson, RL; Wang, S; Xu, L | 1 |
| Dabouz, F; Ducharme, A; Nattel, S; Palardy, M; Racine, N; Roy, D; Talajic, M; Tardif, JC; Tétreault, K; White, M | 1 |
| Bakula, M; Frank, B; Gavranovic, Z; Milicevic, G; Pazur, V | 1 |
| Babarskiene, RM; Stanaitiene, G | 1 |
| Lip, GY; Watson, T | 1 |
| Akcay, S; Dogan, A; Erdogan, D; Karabacak, M; Ozaydin, M; Turker, Y | 1 |
| Földesi, C; Kardos, A; Ladunga, K; Mihálcz, A; Szili-Török, T | 1 |
| Eroğlu, S; Müderrisoğlu, H; Ozbiçer, S; Ozin, B | 1 |
| Breithardt, G; Camm, J; Crijns, H; Dorian, P; Kowey, PR; Le Heuzey, JY; Pedrazzini, L; Prystowsky, EN; Salette, G; Schwartz, PJ; Torp-Pedersen, C; Weintraub, W | 1 |
| Abbate, R; Conti, A; Del Taglia, B; Gensini, GF; Grifoni, S; Mariannini, Y; Michelucci, A; Padeletti, L; Pepe, G; Vanni, S | 1 |
| Eckert, L; Freemantle, N; Lafuente-Lafuente, C; Mitchell, S; Reynolds, M | 1 |
| Kong, DF; Piccini, JP | 1 |
| Apostolakis, S; Lip, GY | 1 |
| Balla, I; Kondili, A; Petrela, E | 1 |
| Sørensen, LK | 1 |
| Birnie, D; Blecher, GE; Borgundvaag, B; Brison, RJ; Clement, CM; Lang, E; Langhan, T; Magee, K; Perry, JJ; Rowe, BH; Stenstrom, R; Stiell, IG; Wells, GA | 1 |
| Alegret, JM; Freire, F; Romero-Menor, C; Viñolas, X | 1 |
| Bouras, G; Deftereos, S; Efremidis, M; Giannopoulos, G; Kaoukis, A; Karageorgiou, S; Katsivas, A; Kossyvakis, C; Panagopoulou, V; Pyrgakis, V; Raisakis, K; Stefanadis, C | 1 |
| Conde, D | 1 |
| Dąbrowski, R; Kiliszek, M; Opolski, G; Ponikowski, P; Włodarczyk, P | 1 |
| Byeon, K; Chun, KJ; Im, SI; Kim, JS; On, YK; Park, KM; Park, SJ | 1 |
| Jankovic, SM; Kostic, M; Paunovic, D; Tesic, D | 1 |
| Al-Khatib, SM; Allen LaPointe, NM; Dai, D; Peterson, ED; Piccini, JP; Thomas, L | 1 |
| Johnson-Davis, KL; Slawson, MH | 1 |
| Bonora, A; Dilda, A; Franchi, E; Maccagnani, A; Olivieri, O; Pistorelli, C; Taioli, G; Turcato, G; Zerman, G | 1 |
| Ge, H; Jiang, H; Li, X; Liu, H | 1 |
| Alexopoulos, D; Chiladakis, J; Chouchoulis, K; Davlouros, P; Kaza, M; Koutsogiannis, N | 1 |
| Balik, M; Kolnikova, I; Kristof, J; Maly, M; Tavazzi, G; Waldauf, P | 1 |
| Balik, M; Brestovansky, P; Brozek, T; Maly, M | 1 |
| Azzam, ZS; Khoury, J | 1 |
| Dai, W; Gandhi, S; Juhaeri, J; Kechemir, H; Lin, S; Tcherny-Lessenot, S; Wang, Y; Wu, C | 1 |
| Duan, H; Hua, Y; Li, Y; Lu, Y; Qiao, L; Wang, C; Yan, S; Zhou, K | 1 |
| Chen, L; Liang, D; Lin, J; Lin, Y; Qi, G; Tian, W; Wang, X | 1 |
| Balik, M; Brestovansky, P; Brozek, T; Duska, F; Flaksa, M; Maly, M; Matousek, V; Otahal, M; Pazout, J; Porizka, M; Rulisek, J; Sachl, R; Smid, O; Stach, Z; Stritesky, M; Svobodova, E; Waldauf, P | 1 |
| Bjeloševič, M; Chalupka, M; Hatala, R; Illíková, V; Olejník, P; Tomko, J | 1 |
| Chen, L; Chen, X; Fan, L; Gong, K; Huang, R; Lin, J; Xu, Z; Zhang, F; Zhang, Y | 1 |
| Duan, X; Gui, Y; Jia, J; Li, S; Liu, CC; Liu, G; Lu, Y; Zhang, M | 1 |
| Chen, CY; Chiou, WR; Chuang, JY; Huang, CC; Kuo, JY; Lee, YH; Liao, FC; Lin, PL; Liu, LY; Su, MI; Tsai, CT; Wu, YJ | 1 |
| Alhazzani, W; Baranchuk, A; Belley-Côté, EP; Benz, AP; Conen, D; Dalmia, S; Devereaux, PJ; Healey, JS; Ibrahim, OA; McIntyre, WF; Um, KJ; Wang, CN; Whitlock, RP | 1 |
| Kapustnick, Y; Lutsenko, R; Sуdorenko, A | 1 |
| Balsam, P; Bula, K; Błaszczyk, R; Ceynowa-Sielawko, B; Ćwiek-Rębowska, E; Dembowski, T; Farkowski, M; Kasprzak, JD; Koziński, M; Krzowski, B; Maciąg, A; Miśkowiec, D; Mizia-Stec, K; Ozierański, K; Peller, M; Szołkiewicz, M; Szwed, H; Wańha, W; Wójcik, M; Wróbel, W; Wybraniec, MT | 1 |
| Aksu, T; Aras, D; Cay, S; Kara, M; Ozcan, F; Ozeke, O; Topaloglu, S | 1 |
| Balsam, P; Bula, K; Błaszczyk, R; Ceynowa-Sielawko, B; Ćwiek-Rębowska, E; Dembowski, T; Farkowski, MM; Kasprzak, JD; Koziński, M; Krzowski, B; Maciąg, A; Miśkowiec, D; Mizia-Stec, K; Ozierański, K; Peller, M; Szołkiewicz, M; Szwed, H; Topp-Zielińska, A; Wańha, W; Wójcik, M; Wróbel, W; Wybraniec, MT | 1 |
| Chang, SH; Chen, SW; Huang, CH; Huang, YC; Huang, YT; Hung, KC; Kuo, CF; Tu, HT; Wang, CL; Wu, VC | 1 |
| Balik, M; Belohlavek, J; Brestovansky, P; Brozek, T; Duska, F; Flaksa, M; Horejsek, J; Jurisinova, I; Kopecky, P; Krajcova, A; Kunstyr, J; Maly, M; Novotny, A; Otahal, M; Pazout, J; Porizka, M; Rulisek, J; Sachl, R; Stach, Z; Svobodova, E; Tencer, T; Trachta, P; Volny, L; Waldauf, P | 1 |
29 review(s) available for amiodarone and propafenone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Incessant idiopathic ventricular tachycardia in infants].
Topics: Amiodarone; Cardiomyopathies; Child, Preschool; Electrocardiography; Female; Flecainide; Follow-Up Studies; Heart Neoplasms; Heart Ventricles; Humans; Infant; Intracranial Embolism and Thrombosis; Male; Prognosis; Propafenone; Tachycardia | 1990 |
Is drug treatment of tachyarrhythmias a science or a lottery?
Topics: Amiodarone; Cardiomyopathy, Hypertrophic; Flecainide; Humans; Propafenone; Tachycardia | 1990 |
Update: cardiac antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Flecainide; Humans; Mexiletine; Piperidines; Propafenone; Propanolamines | 1989 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Clinical pharmacology of old and new antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Biological Availability; Bretylium Compounds; Disopyramide; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Tocainide | 1985 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Propafenone; Propiophenones; Tocainide | 1985 |
[Long-term drug therapy of reciprocating supraventricular tachycardia: re-examination of a selected series of cases, using computerized programs].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Child; Computers; Digoxin; Humans; Medigoxin; Middle Aged; Oxprenolol; Propafenone; Propiophenones; Sotalol; Tachycardia; Verapamil | 1980 |
[Tachycardias: considerations in childhood in the 90s].
Topics: Adenosine; Adolescent; Adult; Amiodarone; Atrial Flutter; Child; Child, Preschool; Electrocardiography; Ergometry; Flecainide; Heart; Heart Ventricles; Humans; Infant; Infant, Newborn; Lidocaine; Middle Aged; Propafenone; Sotalol; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Tachycardia, Ventricular | 1993 |
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Flecainide; Humans; Imidazoles; Pre-Excitation Syndromes; Propafenone; Quinidine; Sotalol; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Verapamil | 1993 |
[Antiarrhythmic treatment after reduction of atrial fibrillation by external shock].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Disopyramide; Electric Countershock; Flecainide; Humans; Propafenone; Quinidine; Recurrence; Sotalol | 1993 |
Is there a need for new antiarrhythmic drugs?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduction System; Humans; Propafenone; Quinidine; Sotalol; Torsades de Pointes | 1996 |
Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Calcium Channel Blockers; Child; Child, Preschool; Digoxin; Flecainide; Humans; Infant; Propafenone; Sotalol; Tachycardia, Atrioventricular Nodal Reentry; Wolff-Parkinson-White Syndrome | 1997 |
Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy.
Topics: Algorithms; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cost-Benefit Analysis; Echocardiography, Transesophageal; Electric Countershock; Flecainide; Humans; Procainamide; Propafenone; Quinidine; Sotalol; Verapamil | 2000 |
Intravenous antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Infusions, Intravenous; Procainamide; Propafenone; Tachycardia, Ventricular | 2001 |
New insights into the mechanisms and management of atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Cardiac Catheterization; Humans; Practice Guidelines as Topic; Propafenone; Sotalol; Warfarin | 2002 |
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Australia; Canada; Controlled Clinical Trials as Topic; Europe; Flecainide; Heart Conduction System; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Phenethylamines; Propafenone; Quinidine; Sotalol; Sulfonamides; Survival Analysis; Therapeutic Equivalency; Treatment Outcome; United States | 2003 |
Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Catheter Ablation; Flecainide; Heart Rate; Humans; Phenethylamines; Practice Guidelines as Topic; Propafenone; Quinidine; Stroke; Sulfonamides; Ventricular Dysfunction, Left | 2003 |
Cost evaluation of rhythm control methods for atrial fibrillation: evidence from CTAF.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Cost-Benefit Analysis; Costs and Cost Analysis; Humans; Propafenone; Sotalol | 2003 |
Atrial fibrillation (acute).
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Diltiazem; Flecainide; Humans; Propafenone; Timolol; Verapamil | 2003 |
Atrial fibrillation (acute).
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Diltiazem; Flecainide; Humans; Propafenone; Verapamil | 2004 |
[Atrial flutter and fibrillation].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Catheter Ablation; Clinical Trials as Topic; Disopyramide; Electric Countershock; Electrocardiography; Emergencies; Flecainide; Heart Rate; Humans; Middle Aged; Pacemaker, Artificial; Propafenone; Quinidine; Recurrence; Sotalol; Sulfonamides; Treatment Outcome; Vasodilator Agents | 2005 |
Atrial fibrillation (recent onset).
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Diltiazem; Flecainide; Humans; Propafenone; Verapamil | 2005 |
[Drug treatment of atrial fibrillation].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Drug Therapy, Combination; Echocardiography; Electric Countershock; Electrocardiography; Flecainide; Heart Diseases; Heart Rate; Humans; Monitoring, Physiologic; Multicenter Studies as Topic; Propafenone; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Time Factors | 2006 |
Atrial fibrillation (acute onset).
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Propafenone; Sotalol | 2008 |
Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Randomized Controlled Trials as Topic; Sotalol; Treatment Outcome | 2011 |
Atrial fibrillation (acute onset).
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Propafenone; Sotalol | 2011 |
Single-dose oral anti-arrhythmic drugs for cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Humans; Network Meta-Analysis; Pharmaceutical Preparations; Propafenone; Randomized Controlled Trials as Topic | 2021 |
46 trial(s) available for amiodarone and propafenone
| Article | Year |
|---|---|
A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.).
Topics: Amiodarone; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Dose-Response Relationship, Drug; Electrocardiography, Ambulatory; Female; Flecainide; Humans; Life Tables; Male; Middle Aged; Myocardial Ischemia; Propafenone; Survival Analysis; Survival Rate; Tachycardia, Ventricular | 1992 |
[Prospective long-term ECG study of 100 patients surviving sudden cardiac death].
Topics: Adult; Aged; Amiodarone; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Rate; Heart Ventricles; Humans; Male; Metoprolol; Middle Aged; Propafenone; Tachycardia, Ventricular | 1992 |
[Comparative study of the efficacy of propafenone and amiodarone in the treatment of chronic ventricular extrasystole].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Cardiac Complexes, Premature; Child; Chronic Disease; Circadian Rhythm; Clinical Trials as Topic; Electrocardiography; Female; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Monitoring, Physiologic; Propafenone; Random Allocation | 1986 |
ICD versus drugs in cardiac arrest survivors: preliminary results of the Cardiac Arrest Study Hamburg.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Female; Follow-Up Studies; Germany; Heart Arrest; Humans; Incidence; Male; Metoprolol; Middle Aged; Propafenone; Prospective Studies; Recurrence; Survival Rate; Tachycardia, Ventricular; Ventricular Fibrillation | 1993 |
[A comparison between propafenone and amiodarone in the conversion to sinus rhythm of atrial fibrillation of recent onset].
Topics: Adult; Aged; Amiodarone; Atrial Fibrillation; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Time Factors | 1994 |
Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg).
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Female; Heart Arrest; Humans; Incidence; Male; Metoprolol; Middle Aged; Propafenone; Prospective Studies; Risk Factors; Tachycardia, Ventricular; Ventricular Fibrillation | 1994 |
Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Female; Heart Arrest; Humans; Male; Metoprolol; Middle Aged; Multivariate Analysis; Propafenone; Prospective Studies; Regression Analysis; Tachycardia, Ventricular; Ventricular Fibrillation | 1993 |
[Prevention of paroxysmal atrial fibrillation with propafenone after withdrawal of amiodarone because of side effects].
Topics: Adult; Aged; Amiodarone; Atrial Fibrillation; Drug Evaluation; Female; Humans; Male; Middle Aged; Propafenone | 1993 |
Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Heart Valve Diseases; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Postoperative Complications; Propafenone; Treatment Outcome | 1995 |
The efficacy and safety of intravenous propafenone versus intravenous amiodarone in the conversion of atrial fibrillation or flutter after cardiac surgery.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Female; Humans; Injections, Intravenous; Male; Middle Aged; Propafenone | 1996 |
Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Electrophysiology; Female; Humans; Male; Middle Aged; Pacemaker, Artificial; Procainamide; Propafenone; Propranolol; Sotalol; Tachycardia, Supraventricular; Verapamil | 1998 |
Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Electrocardiography, Ambulatory; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Prospective Studies; Time Factors | 1998 |
Intravenous propafenone versus intravenous amiodarone in the management of atrial fibrillation of recent onset: a placebo-controlled study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Female; Humans; Infusions, Intravenous; Logistic Models; Male; Middle Aged; Propafenone; Time Factors | 1998 |
Low energy intracardiac cardioversion of persistent atrial fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Catheterization; Echocardiography, Transesophageal; Electric Countershock; Electrocardiography; Female; Heart Function Tests; Humans; Male; Middle Aged; Propafenone; Time Factors; Treatment Outcome | 1998 |
Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Electrocardiography; Female; Humans; Male; Middle Aged; Propafenone; Treatment Outcome | 1999 |
Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation. PARSIFAL Study Group.
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Humans; Male; Middle Aged; Propafenone; Prospective Studies; Single-Blind Method; Treatment Outcome | 1999 |
Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Female; Humans; Male; Middle Aged; Propafenone; Proportional Hazards Models; Prospective Studies; Secondary Prevention; Sotalol | 2000 |
Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation.
Topics: Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Female; Health Status; Humans; Male; Mental Health; Middle Aged; Personality; Propafenone; Quality of Life; Severity of Illness Index; Sex Factors; Sotalol; Surveys and Questionnaires | 2000 |
Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm.
Topics: Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography, Doppler; Female; Flecainide; Heart Conduction System; Humans; Injections, Intravenous; Male; Probability; Propafenone; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2000 |
Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Digoxin; Drug Administration Routes; Electric Countershock; Electrocardiography; Female; Heart Rate; Humans; Length of Stay; Male; Pilot Projects; Procainamide; Prognosis; Propafenone; Prospective Studies; Recurrence; Sotalol | 2000 |
Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm?
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Heart Rate; Humans; Male; Middle Aged; Propafenone; Recurrence; Risk Factors; Sotalol; Treatment Outcome | 2000 |
An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Catheter Ablation; Echocardiography; Female; Flecainide; Follow-Up Studies; Humans; Male; Pacemaker, Artificial; Propafenone; Prospective Studies; Quality of Life; Sotalol; Time Factors | 2002 |
Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Female; Health Status Indicators; Humans; Male; Mental Health; Propafenone; Quality of Life; Recurrence; Regression Analysis; Severity of Illness Index; Sotalol | 2002 |
Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial.
Topics: Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Costs and Cost Analysis; Female; Humans; Male; Middle Aged; Propafenone; Sotalol | 2002 |
Intracardiac low-energy versus transthoracic high-energy direct-current cardioversion of atrial fibrillation: a randomised comparison.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Biomarkers; Creatine Kinase; Electric Countershock; Female; Follow-Up Studies; Heart Conduction System; Humans; Male; Middle Aged; Propafenone; Random Allocation; Recurrence; Severity of Illness Index; Sotalol; Time Factors; Treatment Outcome; Troponin T | 2003 |
Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Atrioventricular Node; Calcium Channel Blockers; Cardiac Surgical Procedures; Electric Countershock; Female; Heart Rate; Heart Ventricles; Humans; Length of Stay; London; Male; Middle Aged; Pilot Projects; Postoperative Complications; Procainamide; Propafenone; Prospective Studies; Recurrence; Sotalol; Survival Analysis; Treatment Outcome | 2003 |
Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: observations from the Canadian Trial of Atrial Fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Health Status Indicators; Humans; Propafenone; Prospective Studies; Quality of Life; Recurrence; Sotalol | 2003 |
Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses.
Topics: Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Follow-Up Studies; Heart Conduction System; Humans; Long-Term Care; Male; Middle Aged; Probability; Propafenone; Prospective Studies; Risk Assessment; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 2004 |
Hybrid therapy with right atrial catheter ablation and previously ineffective antiarrhythmic drugs for the management of atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Postoperative Complications; Propafenone; Prospective Studies; Quality of Life; Sotalol; Surveys and Questionnaires; Treatment Outcome | 2005 |
Stunning of the left atrium after pharmacological cardioversion of atrial fibrillation.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function, Left; Blood Flow Velocity; Chi-Square Distribution; Echocardiography, Transesophageal; Female; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Stunning; Propafenone; Sinoatrial Node; Treatment Outcome | 2005 |
Amiodarone versus Sotalol and Propafenone for prevention of immediate recurrence of atrial fibrillation after internal cardioversion: importance of P wave analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Female; Humans; Male; Propafenone; Prospective Studies; Recurrence; Sotalol | 2006 |
Is circumferential pulmonary vein isolation preferable to stepwise segmental pulmonary vein isolation for patients with paroxysmal atrial fibrillation?
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Female; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Propafenone; Prospective Studies; Pulmonary Veins; Tachycardia, Paroxysmal | 2006 |
Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Drug Monitoring; Female; Flecainide; Follow-Up Studies; Humans; Inpatients; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Propafenone; Recurrence; Sotalol; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome; Ventricular Function, Left; Withholding Treatment | 2007 |
A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Injections, Intravenous; Male; Middle Aged; Procainamide; Propafenone; Prospective Studies; Single-Blind Method | 2007 |
A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Cardiac Pacing, Artificial; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Flecainide; Follow-Up Studies; Humans; Male; Probability; Propafenone; Prospective Studies; Reference Values; Risk Assessment; Single-Blind Method; Sotalol; Statistics, Nonparametric; Survival Rate; Treatment Outcome | 2008 |
[The comparison between the efficiency of different anti-arrhythmic agents in preventing postoperative atrial fibrillation after open heart surgery].
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Diltiazem; Female; Humans; Incidence; Length of Stay; Male; Middle Aged; Postoperative Complications; Propafenone; Prospective Studies; Single-Blind Method; Sotalol; Treatment Outcome; Turkey | 2008 |
Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Female; Humans; Male; Middle Aged; Multivariate Analysis; Propafenone; Prospective Studies; Renin; Renin-Angiotensin System; Secondary Prevention; Sotalol | 2008 |
[Impact of electrical shock waveform and paddle positions on efficacy of direct current cardioversion for atrial fibrillation].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Body Mass Index; Chi-Square Distribution; Data Interpretation, Statistical; Electric Countershock; Female; Humans; Male; Middle Aged; Propafenone; Prospective Studies; Recurrence; Treatment Outcome | 2008 |
Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Cardiac Glycosides; Cardiotonic Agents; Clinical Competence; Female; Flecainide; Health Care Surveys; Health Knowledge, Attitudes, Practice; Heart Rate; Humans; Internationality; Male; Middle Aged; Practice Guidelines as Topic; Propafenone; Prospective Studies; Registries; Sotalol; Surveys and Questionnaires | 2010 |
Management of patients with acute atrial fibrillation in the ED.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Emergency Service, Hospital; Female; Flecainide; Humans; Injections, Intravenous; Length of Stay; Male; Propafenone; Time Factors; Treatment Outcome | 2010 |
Pharmacological conversion of recent atrial fibrillation: a randomized, placebo-controlled study of three antiarrhythmic drugs.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Prospective Studies; Single-Blind Method; Treatment Outcome | 2011 |
Effectiveness of moxonidine to reduce atrial fibrillation burden in hypertensive patients.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Fibrillation; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Propafenone; Sotalol; Sympatholytics; Treatment Outcome | 2013 |
Efficacy of dronedarone versus propafenone in the maintenance of sinus rhythm in patients with atrial fibrillation after electrical cardioversion.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Dronedarone; Electric Countershock; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Propafenone; Recurrence; Time Factors | 2014 |
Efficacy and safety of 1C class antiarrhythmic agent (propafenone) for supraventricular arrhythmias in septic shock compared to amiodarone: protocol of a prospective randomised double-blind study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Propafenone; Prospective Studies; Shock, Septic; Stroke Volume; Tachycardia, Supraventricular; Treatment Outcome; Ventricular Function, Left; Young Adult | 2019 |
Comparison of Amiodarone and Propafenone in Blanking Period after Radiofrequency Catheter Ablation in Patients with Atrial Fibrillation: A Propensity Score-Matched Study.
Topics: Aged; Amiodarone; Atrial Fibrillation; Catheter Ablation; Female; Humans; Male; Middle Aged; Propafenone; Recurrence | 2020 |
Propafenone versus amiodarone for supraventricular arrhythmias in septic shock: a randomised controlled trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Propafenone; Prospective Studies; Shock, Septic; Stroke Volume; Ventricular Function, Left | 2023 |
116 other study(ies) available for amiodarone and propafenone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis).
Topics: Adenosine Triphosphatases; Algorithms; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Binding, Competitive; Caco-2 Cells; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoresceins; Humans; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Radioligand Assay; Rhodamine 123; Stereoisomerism; Verapamil; Vinblastine | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Extrapolation of preclinical pharmacokinetics and molecular feature analysis of "discovery-like" molecules to predict human pharmacokinetics.
Topics: Animals; Biometry; Dogs; Drug Evaluation, Preclinical; Haloperidol; Haplorhini; Humans; Injections, Intravenous; Liver; Liver Circulation; Metabolic Clearance Rate; Mifepristone; Molecular Structure; Molecular Weight; Rats; Reproducibility of Results | 2006 |
Amiodarone and bepridil inhibit anthrax toxin entry into host cells.
Topics: Amiodarone; Animals; Anthrax; Antigens, Bacterial; Bacterial Toxins; Bepridil; Cell Line; Cell Survival; Chloroquine; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Macrophages, Peritoneal; Male; Mice; Molecular Structure; Rats; Rats, Inbred F344; Time Factors | 2007 |
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
Topics: Autophagy; Calcium Channel Blockers; Cell Line, Tumor; Drug Evaluation, Preclinical; Fluspirilene; Glioblastoma; Green Fluorescent Proteins; Humans; Intracellular Membranes; Loperamide; Microtubule-Associated Proteins; Mycotoxins; Peptides; Phagosomes; Phosphatidylinositol Phosphates; Pimozide; Protein Kinases; Recombinant Fusion Proteins; Sirolimus; Small Molecule Libraries; TOR Serine-Threonine Kinases; Trifluoperazine; Zinc Fingers | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; Ion Channels; Kinetics; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Potassium Channel Blockers; Rabbits; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sodium Channels; Torsades de Pointes; Transfection | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Atrial automatic tachycardia in infancy and childhood.
Topics: Adolescent; Amiodarone; Child; Child, Preschool; Electrocardiography, Ambulatory; Female; Flecainide; Humans; Infant; Male; Prognosis; Propafenone; Tachycardia, Ectopic Atrial | 1992 |
[Anti-arrhythmia agents in heart failure].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Flecainide; Humans; Mexiletine; Middle Aged; Propafenone; Quinidine | 1992 |
Is pretransplant antiarrhythmic drug therapy a risk factor?
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Cause of Death; Child; Female; Follow-Up Studies; Heart Transplantation; Humans; Male; Mexiletine; Middle Aged; Postoperative Complications; Premedication; Propafenone; Quinidine; Sotalol; Survival Rate; Transplantation, Heterotopic | 1992 |
Interactions between digitoxin and some antiarrhythmic drugs.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Digitoxin; Drug Interactions; Female; Male; Mexiletine; Propafenone; Rabbits; Radioimmunoassay | 1992 |
Effect of antiarrhythmic drugs on choline uptake in cardiac cells in culture.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cells, Cultured; Chick Embryo; Choline; Dose-Response Relationship, Drug; Encainide; Flecainide; Heart; Lidocaine; Myocardium; Propafenone; Tocainide | 1992 |
[Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Electrocardiography, Ambulatory; Female; Heart Ventricles; Humans; Male; Middle Aged; Propafenone; Retrospective Studies; Tachycardia; Time Factors | 1990 |
The use of associated propafenone in patients with amiodarone-resistant ventricular tachycardia.
Topics: Adult; Aged; Amiodarone; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Electric Stimulation; Electrocardiography; Electrophysiology; Female; Follow-Up Studies; Humans; Male; Middle Aged; Propafenone; Prospective Studies; Tachycardia | 1991 |
Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. Antiarrhythmic Drug Evaluation Group (ADEG).
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography, Ambulatory; Female; Flecainide; Heart Rate; Humans; Male; Middle Aged; Propafenone; Reproducibility of Results; Survival Rate | 1991 |
Arrhythmogenic effects of antiarrhythmic drugs.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Risk Factors; Sotalol; Tachycardia; Verapamil | 1990 |
New hope in atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Propafenone; Quinidine; Sotalol | 1990 |
Noninvasive serial electrophysiological testing using an implanted pacemaker for management of recurrent ventricular tachycardia.
Topics: Aged; Amiodarone; Electrophysiology; Heart Ventricles; Humans; Male; Mexiletine; Pacemaker, Artificial; Propafenone; Propiophenones; Recurrence; Sinoatrial Node; Tachycardia | 1986 |
Block of single cardiac Na+ channels by antiarrhythmic drugs: the effect of amiodarone, propafenone and diprafenone.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cells, Cultured; Ion Channels; Kinetics; Myocardium; Propafenone; Rats; Sodium | 1988 |
Newer antiarrhythmic drugs in children.
Topics: Adolescent; Adult; Amiodarone; Anilides; Arrhythmias, Cardiac; Child; Child, Preschool; Electrocardiography; Encainide; Humans; Infant; Mexiletine; Moricizine; Phenothiazines; Propafenone | 1987 |
[Worsening of ventricular arrhythmia in the dynamic ECG in patients treated with anti-arrhythmia drugs].
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Therapy, Combination; Electrocardiography; Female; Flecainide; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Monitoring, Physiologic; Propafenone | 1988 |
Amiodarone-associated pulmonary fibrosis. Evidence of an immunologically mediated mechanism.
Topics: Amiodarone; Coronary Disease; Drug Therapy, Combination; Electrophoresis, Polyacrylamide Gel; Fluorescent Antibody Technique; Humans; Immunoglobulin G; Lung; Male; Middle Aged; Propafenone; Pulmonary Fibrosis | 1987 |
[Pharmacologic cardioversion with propafenone of stable atrial fibrillation of recent onset].
Topics: Adult; Aged; Amiodarone; Atrial Fibrillation; Electrocardiography; Female; Humans; Injections, Intravenous; Male; Middle Aged; Propafenone | 1987 |
An experimental approach to the choice of antiarrhythmic therapy.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Coronary Disease; Diltiazem; Lidocaine; Mexiletine; Nifedipine; Phenoxybenzamine; Prazosin; Propafenone; Propiophenones; Propranolol; Stellate Ganglion; Verapamil | 1986 |
The yield of programmed ventricular stimulation in mitral valve prolapse patients with ventricular arrhythmias.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Electrophysiology; Female; Heart Arrest; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Mitral Valve Prolapse; Procainamide; Propafenone; Propiophenones; Propranolol; Risk | 1985 |
New drugs in the management of ventricular arrhythmias.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Compounds; Drug Interactions; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Propafenone; Propiophenones; Tocainide | 1984 |
[Effects of anti-arrhythmia agents on heart rate. Significance and importance].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Disopyramide; Electrocardiography; Heart Conduction System; Heart Rate; Humans; Lidocaine; Propafenone; Propiophenones; Quinidine; Verapamil | 1981 |
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Death, Sudden; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tachycardia; Tocainide; Verapamil | 1984 |
[Combinations of some anti-arrhythmia drugs].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Drug Therapy, Combination; Humans; Mexiletine; Propafenone; Propiophenones; Quinidine | 1984 |
[Drug therapy of arrhythmia in coronary cardiopathy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Cardiac Complexes, Premature; Coronary Disease; Disopyramide; Electrocardiography; Humans; Lidocaine; Mexiletine; Piperidines; Propafenone; Propiophenones; Tachycardia; Tocainide | 1983 |
European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Autonomic Nervous System; Cardiac Complexes, Premature; Child; Drug Therapy, Combination; Electrocardiography; Female; Heart Ventricles; Humans; Male; Middle Aged; Propafenone; Propiophenones; Quinidine; Tachycardia; Wolff-Parkinson-White Syndrome | 1984 |
Worsening of arrhythmias during pharmacological treatment.
Topics: Adolescent; Adult; Aged; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Child; Disopyramide; Female; Follow-Up Studies; Humans; Lidocaine; Male; Middle Aged; Nadolol; Piperidines; Propafenone; Propanolamines; Propiophenones; Tocainide | 1984 |
Drug therapy of cardiac arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Biological Availability; Encainide; Half-Life; Humans; Imidazoles; Intestinal Absorption; Kinetics; Lidocaine; Metabolic Clearance Rate; Mexiletine; Propafenone; Propiophenones; Protein Binding; Tachycardia; Tocainide | 1983 |
[Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
Topics: Adult; Aged; Amiodarone; Death, Sudden; Disopyramide; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Arrest; Humans; Male; Metoprolol; Middle Aged; Pindolol; Propafenone; Propiophenones; Tachycardia; Ventricular Fibrillation | 1984 |
Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Central Venous Pressure; Female; Heart Rate; Hemodynamics; Humans; Male; Mexiletine; Myocardial Infarction; Propafenone; Propiophenones; Pulmonary Wedge Pressure; Stroke Volume; Vascular Resistance | 1984 |
[Sustained ventricular tachycardia: induced polymorphism. Clinical and electrophysiological aspects; therapeutic implications].
Topics: Adult; Aged; Ajmaline; Amiodarone; Electric Stimulation; Electrocardiography; Electrophysiology; Female; Heart Block; Heart Ventricles; Humans; Male; Middle Aged; Propafenone; Propiophenones; Tachycardia | 1984 |
Problems of antiarrhythmic treatment in children.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Electrocardiography; Humans; Propafenone; Propiophenones; Tachycardia | 1983 |
[Validity and limits of invasive pharmacological tests in the treatment of malignant ventricular hyperkinetic arrhythmias].
Topics: Adult; Aged; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation; Female; Humans; Male; Mexiletine; Middle Aged; Propafenone; Propiophenones; Tachycardia | 1983 |
Amiodarone is a dose-dependent noncompetitive and competitive inhibitor of T3 binding to thyroid hormone receptor subtype beta 1, whereas disopyramide, lignocaine, propafenone, metoprolol, dl-sotalol, and verapamil have no inhibitory effect.
Topics: Amiodarone; Anti-Arrhythmia Agents; Binding, Competitive; Disopyramide; Dose-Response Relationship, Drug; Humans; Lidocaine; Metoprolol; Propafenone; Receptors, Thyroid Hormone; Sotalol; Triiodothyronine; Verapamil | 1995 |
[Importance of programmed ventricular stimulation in the evaluation of proarrhythmic effects of orally administered anti-arrhythmia agents].
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Female; Humans; Male; Middle Aged; Propafenone | 1995 |
Neurotoxic action of some antiarrhythmic agents: comparative effects of propafenone, lidocaine and amiodarone on leech Retzius nerve cell.
Topics: Action Potentials; Amiodarone; Animals; Calcium; Ganglia, Invertebrate; Leeches; Lidocaine; Neurons; Patch-Clamp Techniques; Potassium; Potassium Channels; Propafenone | 1995 |
Chaotic atrial rhythm in children.
Topics: Amiodarone; Arrhythmias, Cardiac; Drug Evaluation; Electrocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Atria; Humans; Infant; Infant, Newborn; Male; Propafenone; Retrospective Studies | 1995 |
Treatment of atrial ectopic tachycardia in infants < 6 months old.
Topics: Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Digoxin; Drug Combinations; Drug Resistance; Echocardiography; Electrocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans; Infant; Male; Propafenone; Remission Induction; Tachycardia, Ectopic Atrial | 1995 |
Sixty-six episodes of ventricular fibrillation within four hours: electrical stability restored by propafenone.
Topics: Amiodarone; Electric Countershock; Humans; Injections, Intravenous; Lidocaine; Male; Middle Aged; Myocardial Infarction; Propafenone; Recurrence; Time Factors; Ventricular Fibrillation | 1994 |
Antiarrhythmic drugs in the management of atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Flecainide; Heart; Humans; Propafenone; Quinidine | 1993 |
[The efficacy of intravenous propafenone and amiodarone in the conversion of recent-onset atrial fibrillation. A 1-year follow-up with oral treatment].
Topics: Administration, Oral; Adult; Aged; Amiodarone; Atrial Fibrillation; Drug Evaluation; Female; Follow-Up Studies; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Propafenone; Recurrence; Time Factors | 1993 |
[The effect of treatment with propafenone, metoprolol and amiodarone on lymphocyte sodium efflux and level of cAMP in serum].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cyclic AMP; Female; Heart Diseases; Humans; Lymphocytes; Male; Metoprolol; Middle Aged; Propafenone; Sodium | 1995 |
Activation of the hemostatic mechanism after pharmacological cardioversion of acute nonvalvular atrial fibrillation.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Antithrombin III; Atrial Fibrillation; Biomarkers; Disease Susceptibility; Female; Fibrinopeptide A; Flecainide; Hemostasis; Humans; Male; Middle Aged; Peptide Hydrolases; Propafenone; Thrombin; Thromboembolism | 1997 |
[Circulatory arrest after combined intravenous drugs for the treatment of orthodromic circular tachycardia of Wolff-Parkinson-White syndrome].
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Female; Heart Arrest; Humans; Middle Aged; Propafenone; Tachycardia, Paroxysmal; Wolff-Parkinson-White Syndrome | 1997 |
Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Catheter Ablation; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; Propafenone; Quinidine | 1998 |
Electropharmacologic effects of class I and class III antiarrhythmia drugs on typical atrial flutter: insights into the mechanism of termination.
Topics: Adult; Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Flutter; Atrial Function; Cardiac Catheterization; Electrophysiology; Female; Heart Conduction System; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Sulfonamides | 1998 |
Intravenous amiodarone versus propafenone for atrial fibrillation and flutter after cardiac surgery: a note of caution.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; Heart Rate; Humans; Infusions, Intravenous; Propafenone; Risk Factors; Treatment Outcome | 1996 |
Persistent atrial flutter in patients treated for atrial fibrillation with amiodarone and propafenone: electrophysiologic characteristics, radiofrequency catheter ablation, and risk prediction.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Female; Humans; Male; Middle Aged; Propafenone | 1999 |
Amiodarone to prevent recurrence of atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Disease; Humans; Hypertrophy, Left Ventricular; Propafenone; Secondary Prevention; Sotalol | 2000 |
Propafenone-induced ataxia: report of three cases.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Ataxia; Atrial Fibrillation; Brain; Female; Humans; Male; Propafenone; Tomography, X-Ray Computed | 2000 |
[Atrial fibrillation after open-heart surgery--incidence, prevention and treatment].
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Electric Countershock; Female; Humans; Incidence; Male; Metoprolol; Middle Aged; Propafenone; Retrospective Studies; Treatment Outcome | 2000 |
Differential effects of dofetilide, amiodarone, and class lc drugs on left and right atrial refractoriness and left atrial vulnerability in pigs.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrial Function, Left; Atrial Function, Right; Flecainide; Male; Phenethylamines; Propafenone; Sulfonamides; Swine | 2001 |
Altered values of heart rate variability in patients with relapse of atrial fibrillation during the first week after electrical cardioversion: preliminary data.
Topics: Aged; Amiodarone; Atrial Fibrillation; Circadian Rhythm; Electric Countershock; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Middle Aged; Observer Variation; Predictive Value of Tests; Propafenone; Recurrence; Sensitivity and Specificity; Time Factors; Vasodilator Agents; Verapamil | 2001 |
Visual compatibility of sodium nitroprusside with other injectable medications given to pediatric patients.
Topics: Amiodarone; Cardiovascular Diseases; Catheterization, Central Venous; Chemical Precipitation; Child; Color; Drug Combinations; Drug Incompatibility; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Nitroprusside; Pharmaceutical Solutions; Postoperative Care; Propafenone; Vasodilator Agents | 2001 |
[The treatment of postoperative junctional ectopic tachycardia].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Combined Modality Therapy; Female; Heart Diseases; Humans; Hypothermia, Induced; Infant; Injections, Intravenous; Male; Postoperative Complications; Propafenone; Retrospective Studies; Tachycardia, Ectopic Junctional | 2002 |
Amiodarone: pearl or peril?
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cost-Benefit Analysis; Humans; Propafenone; Sotalol | 2002 |
Congenital junctional ectopic tachycardia in children and adolescents: a 20 year experience based study.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Child; Digoxin; Drug Therapy, Combination; Female; Humans; Male; Propafenone; Tachycardia, Ectopic Junctional | 2002 |
Excitable gap composition in the presence of antiarrhythmic drugs in common human atrial flutter.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Female; Heart Conduction System; Humans; Male; Middle Aged; Propafenone; Research Design; Sotalol; Treatment Outcome | 2003 |
Long-term follow-up of sudden cardiac arrest survivors and electrophysiologically guided antiarrhythmic therapy.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electrophysiologic Techniques, Cardiac; Female; Follow-Up Studies; Heart Arrest; Humans; Male; Mexiletine; Middle Aged; Prognosis; Propafenone; Sotalol; Survivors; Time Factors; Treatment Outcome | 2003 |
High-throughput screening for the assessment of time-dependent inhibitions of new drug candidates on recombinant CYP2D6 and CYP3A4 using a single concentration method.
Topics: Amiodarone; Animals; Baculoviridae; Binding, Competitive; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diltiazem; Enzyme Inhibitors; Fluorescence; Humans; Inhibitory Concentration 50; Ketoconazole; Miconazole; Midazolam; Propafenone; Quinolines; Recombinant Proteins; Troleandomycin; Verapamil | 2004 |
Atrial fibrillation: rate control often better than rhythm control.
Topics: Adult; Aged; Amiodarone; Anticoagulants; Arrhythmia, Sinus; Atrial Fibrillation; Canada; Disopyramide; Electric Countershock; Flecainide; Heart Rate; Humans; Netherlands; Platelet Aggregation Inhibitors; Propafenone; Quinidine; Sotalol; United States | 2004 |
[Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiology Service, Hospital; Electric Countershock; Female; Follow-Up Studies; Hospital Departments; Humans; Hungary; Male; Middle Aged; Prajmaline; Propafenone; Quinidine; Retrospective Studies; Sotalol | 2004 |
Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Function; Atropine; Biphenyl Compounds; Chromans; Flecainide; Heart Atria; Hydantoins; Imidazoles; Imidazolidines; Male; Phenethylamines; Piperazines; Potassium Channel Blockers; Potassium Channels; Propafenone; Propanolamines; Sotalol; Sulfonamides; Swine; Ventricular Function | 2004 |
Limitations to antiarrhythmic drug use in patients with atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Contraindications; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Quinidine; Registries; Sotalol | 2004 |
Different clinical courses and predictors of atrial fibrillation occurrence after transisthmic ablation in patients with preablation lone atrial flutter, coexistent atrial fibrillation, and drug induced atrial flutter.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Catheter Ablation; Cohort Studies; Disease-Free Survival; Echocardiography; Female; Flecainide; Follow-Up Studies; Forecasting; Humans; Longitudinal Studies; Male; Middle Aged; Propafenone; Prospective Studies; Recurrence; Risk Factors; Time Factors | 2004 |
Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
Topics: Adult; Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chi-Square Distribution; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Prospective Studies; Sulfonamides; Treatment Outcome | 2005 |
"Pseudosinus rhythm": what is the mechanism?
Topics: Amiodarone; Atrial Fibrillation; Catheter Ablation; Female; Humans; Middle Aged; Propafenone; Pulmonary Veins; Vena Cava, Superior | 2005 |
Drug therapy of paroxysmal atrial fibrillation in the elderly over 75 years old.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cardiac Glycosides; Female; Heart Rate; Humans; Lanatosides; Male; Nausea; Propafenone | 2006 |
Acute pancreatitis and amiodarone: a case report.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Pancreatitis; Propafenone; Tachycardia | 2007 |
Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; DNA Mutational Analysis; Electrocardiography; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Female; Finland; Flecainide; Founder Effect; Genetic Predisposition to Disease; Genetic Testing; Heart Conduction System; Humans; KCNQ1 Potassium Channel; Long QT Syndrome; Male; Middle Aged; Mutation; Propafenone; Risk Factors; Sotalol; Torsades de Pointes; Treatment Outcome | 2007 |
Atrial-selective sodium channel block as a strategy for suppression of atrial fibrillation.
Topics: Acetanilides; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Dogs; Electrophysiology; Heart Atria; Humans; Lidocaine; Piperazines; Propafenone; Ranolazine; Sodium Channel Blockers; Ventricular Function | 2008 |
Effect of amiodarone on Kv1.4 channel C-type inactivation: comparison of its effects with those induced by propafenone and verapamil.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; DNA, Complementary; Dose-Response Relationship, Drug; Electrophysiology; Female; Kv1.4 Potassium Channel; Oocytes; Patch-Clamp Techniques; Propafenone; Verapamil; Xenopus laevis; Xenopus Proteins | 2008 |
Successful conversion of recent-onset atrial fibrillation by sequential administration of up to three antiarrhythmic drugs.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Administration Schedule; Electric Countershock; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Prospective Studies; Quinidine; Treatment Outcome; Young Adult | 2008 |
The effect of pretreatment with renin-angiotensin-aldosterone system blockers on cardioversion success and acute recurrence of atrial fibrillation.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Electric Countershock; Female; Humans; Male; Middle Aged; Propafenone; Prospective Studies; Renin-Angiotensin System; Secondary Prevention; Treatment Outcome | 2009 |
[Effectiveness of D,L-sotalol in post-ablative atrial arrhythmias in patients with atrial fibrillation treated with radiofrequency ablation].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Case-Control Studies; Catheter Ablation; Drug Administration Schedule; Female; Follow-Up Studies; Heart Atria; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Propafenone; Pulmonary Veins; Research Design; Sample Size; Sotalol; Tachycardia, Supraventricular; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
A case of myotonic dystrophy presenting with ventricular tachycardia and atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Defibrillators, Implantable; Electric Countershock; Electrocardiography; Female; Humans; Infusions, Intravenous; Mexiletine; Middle Aged; Myotonic Dystrophy; Propafenone; Tachycardia, Ventricular; Ultrasonography; Ventricular Dysfunction, Left | 2009 |
Mixed treatment comparisons for atrial fibrillation: evidence network or bewildering entanglement?
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Evidence-Based Medicine; Flecainide; Humans; Propafenone; Sotalol; Treatment Outcome | 2011 |
A liquid chromatography-electrospray tandem mass spectrometry method for the determination of antiarrhythmic drugs and their metabolites in forensic whole blood samples.
Topics: Amiodarone; Anti-Arrhythmia Agents; Calibration; Chromatography, High Pressure Liquid; Chromatography, Liquid; Forensic Toxicology; Humans; Limit of Detection; Propafenone; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2012 |
Use of rate control medication before cardioversion of recent-onset atrial fibrillation or flutter in the emergency department is associated with reduced success rates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Canada; Electric Countershock; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Premedication; Procainamide; Propafenone; Retrospective Studies; Treatment Outcome | 2012 |
[Predictors of reversion to sinus rhythm previous to electrical cardioversion in patients with persistent atrial fibrillation treated with anti-arrhythmic drugs].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Body Mass Index; Comorbidity; Diabetes Mellitus; Female; Flecainide; Heart Rate; Heart Valve Diseases; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Prognosis; Propafenone; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Recovery of Function; Remission Induction; Sotalol; Time Factors; Treatment Outcome | 2013 |
Conversion of recent onset atrial fibrillation: which drug is faster?
Topics: Administration, Oral; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Flecainide; Humans; Injections, Intravenous; Propafenone; Pyrrolidines; Time Factors | 2013 |
Cardioversion of Atrial Fibrillation (RHYTHM-AF) International Registry in Poland.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Female; Heart Rate; Humans; Male; Middle Aged; Poland; Propafenone; Registries; Treatment Outcome | 2014 |
Analysis of the cost-effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cost-Benefit Analysis; Disease-Free Survival; Humans; Models, Theoretical; Propafenone; Serbia; Sotalol | 2015 |
Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Databases, Factual; Dronedarone; Drug Substitution; Female; Flecainide; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Propafenone; Sotalol | 2015 |
Quantitation of Flecainide, Mexiletine, Propafenone, and Amiodarone in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Topics: Amiodarone; Anti-Arrhythmia Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Flecainide; Humans; Mexiletine; Propafenone; Tandem Mass Spectrometry | 2016 |
Efficacy and safety in pharmacological cardioversion of recent-onset atrial fibrillation: a propensity score matching to compare amiodarone vs class IC antiarrhythmic drugs.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Female; Flecainide; Humans; Male; Middle Aged; Pharmacological Phenomena; Propafenone; Propensity Score; Retrospective Studies; Treatment Outcome | 2017 |
Predictors of Pharmacological Therapy of Ectopic Atrial Tachycardia in Children.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Child; Child, Preschool; China; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Logistic Models; Male; Metoprolol; Multivariate Analysis; Propafenone; Retrospective Studies; Sotalol; Tachycardia, Ectopic Atrial; Treatment Outcome | 2017 |
Impact of QT interval prolongation following antiarrhythmic drug therapy on left ventricular function.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Echocardiography; Electrocardiography; Female; Heart Rate; Humans; Male; Propafenone; Sotalol; Ventricular Function, Left | 2017 |
Propafenone for supraventricular arrhythmias in septic shock-Comparison to amiodarone and metoprolol.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Critical Care; Electric Countershock; Female; Humans; Male; Metoprolol; Middle Aged; Propafenone; Retrospective Studies; Shock, Septic; Tachycardia, Supraventricular; Treatment Outcome | 2017 |
Reply.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Metoprolol; Propafenone; Shock, Septic | 2018 |
Propafenone for supraventricular arrhythmias in septic shock-Comparison to amiodarone and metoprolol.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Metoprolol; Propafenone; Shock, Septic | 2018 |
Assessing the Risk for Peripheral Neuropathy in Patients Treated With Dronedarone Compared With That in Other Antiarrhythmics.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Databases, Factual; Dronedarone; Female; Flecainide; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Propafenone; Retrospective Studies; Sotalol | 2018 |
A delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia with a mutant of RYR2 at c.7580T>G for 6 years in a 9-year-old child.
Topics: Amiodarone; Anti-Arrhythmia Agents; Child; Death, Sudden, Cardiac; Delayed Diagnosis; Electrocardiography; Exercise Test; Genetic Testing; Humans; Male; Metoprolol; Mutation; Physical Exertion; Propafenone; Ryanodine Receptor Calcium Release Channel; Syncope; Tachycardia, Ventricular | 2018 |
Treatment with verapamil for restoration of sinus rhythm in atrial fibrillation with rapid ventricular response: A case report.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Comorbidity; Female; Humans; Propafenone; Verapamil | 2019 |
Supraventricular tachyarrhythmias during the intrauterine, neonatal, and infant period: A 10-year population-based study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Pregnancy; Propafenone; Retrospective Studies; Slovakia; Sotalol; Tachycardia, Supraventricular | 2020 |
Direct analysis in real time-mass spectrometry for rapid quantification of five anti-arrhythmic drugs in human serum: application to therapeutic drug monitoring.
Topics: Amiodarone; Anti-Arrhythmia Agents; Chromatography, High Pressure Liquid; Computer Systems; Diltiazem; Drug Monitoring; Humans; Metoprolol; Pharmaceutical Preparations; Propafenone; Tandem Mass Spectrometry; Verapamil | 2020 |
Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Diseases; Dronedarone; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Propafenone; Retrospective Studies; Rivaroxaban; Taiwan | 2021 |
COMBINED PHARMACOLOGICAL THERAPY INCLUDING SEVERAL ANTIARRHYTHMIC AGENTS FOR TREATMENT OF DIFFERENT DISORDERS OF CARDIAC RHYTHM.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Propafenone; Sotalol | 2021 |
Efficacy and safety of antazoline for cardioversion of atrial fibrillation: propensity score matching analysis of a multicenter registry (CANT II Study).
Topics: Aged; Amiodarone; Antazoline; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Female; Humans; Male; Propafenone; Propensity Score; Registries; Retrospective Studies; Treatment Outcome | 2022 |
Propafenone use in coronary artery disease patients undergoing atrial fibrillation ablation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Disease; Death, Sudden, Cardiac; Humans; Longitudinal Studies; Propafenone; Retrospective Studies; Tachycardia, Ventricular; Treatment Outcome | 2022 |
Pharmacological Cardioversion in Patients with Recent-Onset Atrial Fibrillation and Chronic Kidney Disease Subanalysis of the CANT II Study.
Topics: Amiodarone; Antazoline; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Female; Humans; Male; Propafenone; Renal Insufficiency, Chronic; Treatment Outcome | 2022 |
Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Dronedarone; Humans; Ischemic Stroke; Propafenone; Stroke | 2023 |